KT&G and Kolon Industries partner for eco-friendly cigarette filters

Feb.21.2023
KT&G and Kolon Industries partner for eco-friendly cigarette filters
KT&G and Kolon Industries collaborate to develop eco-friendly cigarette filters using Lyocell fiber.

On February 21st, KT&G announced a partnership with Kolon Industries to jointly develop cigarette filters made from environmentally-friendly Lyocell fibers. The signing ceremony between the two parties took place on February 20th at KT&G's headquarters in Seoul.


Two companies plan to establish a promotion commission to manage business progress and make major decisions, and in the future, they will accelerate the development of cigarette filter tips using environmentally friendly materials.


Kim Jin-han, KT&G's strategic planning director, stated that the company will continue to fulfill its environmental responsibilities and promote ESG management in accordance with global standards. Yoon Kwang-bok, managing director of Kolon Industries, expressed hopes of strengthening communication and cooperation between the two companies while jointly developing environmentally friendly materials based on natural raw materials such as the Lyocell pulp.


Reference sources.


KT&G collaborates with Kolon Industries to jointly develop eco-friendly cigarette filters.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Philip Morris International's five-year EU investment exceeds €43 billion, generating nearly €290 billion in economic impact
Philip Morris International's five-year EU investment exceeds €43 billion, generating nearly €290 billion in economic impact
According to Ernst & Young Parthenon research, Philip Morris International (PMI) invested over 43 billion euros in the EU from 2019 to 2023. It brought nearly 290 billion euros in economic impact, supported about 1 million jobs (21,500 direct hires in 2023), put 19.6 billion euros into over 45,000 suppliers, spent 625 million euros on tobacco leaf procurement, 2.3 billion euros on R&D, and exported over 33 billion euros to non-EU markets.
Sep.19 by 2FIRSTS.ai
Research Brief | Nicotine pouch use among Canadian adolescents has drawn close to cigarettes
Research Brief | Nicotine pouch use among Canadian adolescents has drawn close to cigarettes
Study results show that nicotine pouches are the third most commonly used nicotine product among adolescents. Current use stands at 2.6%, close to cigarettes (3.0%). Risk of use is higher among cisgender boys, gender-diverse youth, students with poor academic performance, and those with part-time jobs; more than 70% of nicotine-pouch users also vape.
Sep.04 by 2FIRSTS.ai
InterTabac 2025 Highlights Europe’s Vaping Dilemma: Tighter Regulation, Constrained Innovation
InterTabac 2025 Highlights Europe’s Vaping Dilemma: Tighter Regulation, Constrained Innovation
According to 2Firsts’ on-site observations, the vaping halls at InterTabac 2025 have visibly cooled: fewer exhibitors, a weaker presence from major brands, and scarce stage activations; new product momentum is weak and homogenization has intensified. Tightening regulation and policy uncertainty are squeezing innovation, pushing companies to replicate proven models—overall, a “cautious showcase.”
Sep.19 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
Cambodia Enforces Full Ban on E-Cigarettes and Shisha to Protect Youth
Cambodia Enforces Full Ban on E-Cigarettes and Shisha to Protect Youth
Cambodian Prime Minister Hun Manet signs order to strengthen enforcement of e-cigarette and shisha bans, citing health risks and youth usage.
Oct.23 by 2FIRSTS.ai
Texas Bans Most Disposable Vapes, Sparking Business and Health Concerns
Texas Bans Most Disposable Vapes, Sparking Business and Health Concerns
A new Texas law prohibiting the sale and marketing of most disposable e-cigarettes and THC vapes has taken effect, drawing criticism from retailers, consumers, and public health experts who warn it may fuel illegal markets and limit safer consumption options.
Sep.09